Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.
Ateequllah Hayat, PhD
Advertisement
Ateequllah Hayat, PhD, is an academic scientist with industry experience and a lecturer in drug development at City St. George, University of London.
Articles by Ateequllah Hayat, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
2
New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq
3
Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries
4
Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs
5
